Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hirayama

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 1, 1992
[Use of water-soluble beta-cyclodextrin derivatives as carriers of anti-inflammatory drug biphenylylacetic acid in rectal delivery]H Arima, T Kondo, T Irie, et al.
Journal of Pharmaceutical Sciences|October 4, 2000
Release characteristics of a short-chain fatty acid, n-butyric acid, from its beta-cyclodextrin ester conjugate in rat biological mediaF Hirayama, T Ogata, H Yano, et al.
The Journal of Antibiotics|October 1, 1983
Safracins, new antitumor antibiotics. I. Producing organism, fermentation and isolationY Ikeda, H Idemoto, F Hirayama, et al.
European Journal of Pharmacology|August 26, 1998
Antithrombotic effect of YM-75466 is separated from its effect on bleeding time and coagulation timeK Sato, S Kaku, F Hirayama, et al.
Gut|April 16, 2002
Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury in Mongolian gerbilsN Yoshida, N Sugimoto, F Hirayama, et al.
British Journal of Pharmacology|March 4, 1998
Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding timeK Sato, T Kawasaki, N Hisamichi, et al.
Vox Sanguinis|May 9, 2015
A hollow-fibre column system to effectively prepare washed plateletsS Tanaka, T Hayashi, S Sugaya, et al.
Thrombosis and Haemostasis|March 11, 1998
Comparative studies of an orally-active factor Xa inhibitor, YM-60828, with other antithrombotic agents in a rat model of arterial thrombosisT Kawasaki, K Sato, Y Sakai, et al.
International Journal of Pharmaceutics|March 4, 1999
Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solutionK Miyake, T Irie, H Arima, et al.
Japanese Journal of Pharmacology|November 26, 1998
Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in miceK Sato, Y Taniuchi, T Kawasaki, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 1, 1992
[Use of water-soluble beta-cyclodextrin derivatives as carriers of anti-inflammatory drug biphenylylacetic acid in rectal delivery]H Arima, T Kondo, T Irie, et al.
Journal of Pharmaceutical Sciences|October 4, 2000
Release characteristics of a short-chain fatty acid, n-butyric acid, from its beta-cyclodextrin ester conjugate in rat biological mediaF Hirayama, T Ogata, H Yano, et al.
The Journal of Antibiotics|October 1, 1983
Safracins, new antitumor antibiotics. I. Producing organism, fermentation and isolationY Ikeda, H Idemoto, F Hirayama, et al.
European Journal of Pharmacology|August 26, 1998
Antithrombotic effect of YM-75466 is separated from its effect on bleeding time and coagulation timeK Sato, S Kaku, F Hirayama, et al.
Gut|April 16, 2002
Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury in Mongolian gerbilsN Yoshida, N Sugimoto, F Hirayama, et al.
British Journal of Pharmacology|March 4, 1998
Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding timeK Sato, T Kawasaki, N Hisamichi, et al.
Vox Sanguinis|May 9, 2015
A hollow-fibre column system to effectively prepare washed plateletsS Tanaka, T Hayashi, S Sugaya, et al.
Thrombosis and Haemostasis|March 11, 1998
Comparative studies of an orally-active factor Xa inhibitor, YM-60828, with other antithrombotic agents in a rat model of arterial thrombosisT Kawasaki, K Sato, Y Sakai, et al.
International Journal of Pharmaceutics|March 4, 1999
Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solutionK Miyake, T Irie, H Arima, et al.
Japanese Journal of Pharmacology|November 26, 1998
Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in miceK Sato, Y Taniuchi, T Kawasaki, et al.
Pageof 13